Recent updates point at significant developments within
Bio-Techne Corp TECH. There has been an expansion of their
partnership with Leica Biosystems to enable protease-free workflows for automated spatial multiomics. Bio-Techne has also
opened a new Customer Experience Centre in Germany, intending to provide comprehensive support to European clientele.
Collaborations have been enhanced with Leica Biosystems, aiming to enhance spatial multiomics research capabilities. The company outperforms with its Q2
earnings and revenue estimates which led to a surge in premarket stock. Notably, the company began shipping Leo, a next-generation high-throughput Simple Western System, set to revolutionize protein analysis. This comes after successful second claims of reverse engineering by
Miltenyi Biotec, strengthening the company's innovative mark. Lastly, there's also newly stricken
partnerships with Alzpath advance neurodegenerative disease research and an agreement with MedsanTek to expand portfolio in Turkey.
Bio-Techne Corp TECH News Analytics from Fri, 18 Nov 2022 08:00:00 GMT to Wed, 02 Apr 2025 14:40:49 GMT -
Rating 8
- Innovation 9
- Rumor -7
